The Permian basin is starting to see decline rates from shale wells accelerate, a trend that could be the result of too much drilling. Shale wells suffer from steep decline rates. A rush of output occurs at first, but almost immediately after the well
As promised, Pfizer Inc (PFE) reported quarterly earnings during pre-market, but the anticipated release failed to impress after the pharmaceutical company didn't maintain expectations. Revenue missed Wall Street projections, dipping 2% from $13.15 billion to $12.9 billion. Pfizer rose 1.5% in after-hours trading to $32.42 a share. "Every time I see the Pfizer quarter I recognize why they needed to do the Allergan [plc] (AGN) deal," said Jim Cramer, TheStreet's founder and portfolio manager of Action Alerts PLUS Charitable Trust. Cramer continued by expressing his confusion about Pfizer's lack of breakthrough work and their inability to distinguish themselves from their competition. Pfizer's
At a recent conference, retirement experts concluded that the lack of an easy drawdown mechanism in 401(k) plans was the major challenge facing the 401(k) system. In 2014, the Treasury Department and the IRS issued guidance that made longevity annuities accessible to 401(k) plans and that enabled target date funds to include annuity contracts either as a default or as a regular investment option. But individual plan sponsors feel under siege by lawsuits and see little payoff to being innovative. At the same time, Congress is unlikely to mandate that annuities be a part of 401(k) arrangements. So we are at a standstill. Millions of Americans — having been told that their retirement plans are automatic